Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
Biotech
Merck seals $610M deal to acquire preclinical biotech Caraway
Merck & Co. is rounding off the year by swelling its preclinical pipeline with a selection of programs aimed at Parkinson’s disease and beyond.
James Waldron
Nov 21, 2023 8:09am
AbbVie continues Parkinson's pursuit with $110M Mitokinin buy
Oct 5, 2023 10:30am
Carl June, Vertex execs among 2024's Breakthrough Prize winners
Sep 15, 2023 8:00am
New test aims to spot signs of Parkinson's from a teardrop
Sep 12, 2023 12:43pm
Serina uses merger with ailing AgeX as chance to go public
Aug 30, 2023 9:10am
Bayer preps phase 2 after Parkinson's cell therapy scores win
Aug 28, 2023 2:00am
